07:01 AM EDT, 08/07/2024 (MT Newswires) -- CVS Health ( CVS ) reported Q2 adjusted earnings of $1.83 per diluted share on Wednesday, down from $2.21 a year earlier.

Analysts polled by Capital IQ expected $1.73.

Revenue for the quarter ended June 30 was $91.23 billion compared with $88.92 billion a year earlier.

Analysts surveyed by Capital IQ expected $91.43 billion.

The company trimmed its 2024 adjusted EPS guidance to $6.40 to $6.65 from at least $7.00.

Price: 56.87, Change: -1.47, Percent Change: -2.52